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INTRODUCTION
Insulin-like growth factor-I (IGF-I) functions as an anabolic growth factor for
bone in vivo by stimulating preosteoblast proliferation and osteoblast differentiation.
Studies in transgenic mouse models suggest the importance of paracrine/autocrine actions
of IGF-I in addition to its endocrine functions. The purpose of this present study was to
investigate the paracine/autocrine effects of IGF-I on proliferation and differentiation of
cells of the osteoblast lineage. Primary osteoblast cultures were obtained by serial
digestion of neonatal calvariae from wild type (WT) and pOBCoI3.6-IGF transgenic (TG)
mice. These mice overexpress IGF-I in cells of the osteoblast lineage. Cell growth was
significantly increased at day 4 in TO cultures compared to WT. AP activity was
measured as an early differentiation marker on days 14 and 21. Compared to WT cells,
there was a significant decrease in AP activity in TG cells on day 21. The expression of
osteoblast differentiation markers including Col1a1, BSP, and OC mRNA were not
significantly affected on days 7, 14 and 21. On day 21, von Kossa staining for
mineralization and expression of CoI2.3-GFP, a late-stage marker of osteoblast
differentiation, were not altered in TO cultures. In conclusion, IGF-I overexpression
driven by a 3.6-kb Col1a1 pronl0ter fragment in primary calvarial osteoblasts transgenic
mice showed an increase in osteoblast proliferation and had no significant effect on
differentiation.
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2LITERATURE REVIEW
Bone is a specialized connective tissue that has three functions: mechanical
support, protection of vital organs and maintenance of mineral homeostasis. Bone
remodeling is the continuous coupled cycle of breakdown and rebuilding. Bone is
composed of two nlajor cell types: osteoblasts are bone-foffiling cells; osteoclasts are
bone resorbing cells. Bone formation and bone resorption are coordinated as a part of
tllrnover mechanism of bone remodeling in which resorption occurs first, followed by
formation at the same site in discrete units throughout the skeleton. Osteoclasts are
derived from haemopoeitic stem cells in the bone marrow, specifically cells of the
monocyte-macrophage lineage. Local factors are released in the bone microenvironment
upon hormonal and/or mechanical signals, which activate preosteoclasts to differentiate
into large multinucleated osteoclasts. Multinucleated osteoclasts attach to bone and
secrete hydrogen ions and lysosomal enzymes, which resorb the bone mineral and matrix
in that defined area. After bone resorption, osteoclasts probably undergo apoptosis.
Macrophage-like mononuclear cells now cover the surface and form a proteoglycan-
cement line, which demarcates the resorption cavity. Then, preosteoblasts proliferate and
differentiate into mature osteoblasts, which originate from pluripotent mesenchymal stem
cells of the bone marrow. Mesenchymal cells also carry the potential to become
fibroblasts, chondrocytes, adipocytes, or muscle cells. Osteoblasts synthesize and secrete
3type I collagen, alkaline phosphatase osteocalcin, osteonectin, bone sialoprotein and other
matrix proteins that comprise osteoid, which eventually becomes mineralized to form
bone. Other cells of the osteoblast lineage include lining cells, which are found opposed
to inactive bone surfaces, and osteocytes, which have become entrapped within the bone
matrix (1).
The bone formation that occurs during development and remodeling requires
osteoblast proliferation and differentiation. Regulation of these biological processes
involves sequential expression of cell growth and tissue specific genes, giving rise to a
series of regulatory signals. Each component of regulatory cascade indicates a step in
physiological control. The expression of cell cycle and cell growth regulating genes
(proliferation) and genes associated with the maturation (differentiation) of the osteoblast
phenotype changes as the extracellular matrix (ECM) develops mineral in normal cell
cultures. These genes include histone (H4), TGF-B, fibronectin (FN), type I collagen
(COL), osteopontin (OP), alkaline phosphatase (AP), matrix Gla protein (MGP),
osteocalcin (OC) and collagenase (C'ASE). There are three major stages ill the
osteogenic developmental sequence: proliferation, matrix development and maturation
and, mineralization. There are two traIlsition points in the developmental sequence. The
first is at the completion of proliferation when genes associated with matrix development
and maturation are up-regulated; the second occurs at the onset of extracellular nlatrix
mineralization. The proliferation period supports the synthesis of a type I collagen-
fibronectin ECM. Expression of osteoblast phenotypic genes such as OC and BSP are
4suppressed during the growth period. In the post-proliferative period, genes such as BSP
and OC are activated. Mature osteoblasts and osteocytes are associated with OC
expression and the mineralized nodules (2).
Bone remodeling depends on many factors. The insulin-like growth factors (IGFs)
are important al1abolic effectors during bone remodelil1g. IGFs are 7-kDa proteins that
shares structural homology with proinsulin (3). IGFs can act in an autocrine/paracrine
fashion to regulate bone cell differentiation and function. There are two known IGF
peptides: IGF-I and IGF-II. The actions of IGFs on bone metabolism are modulated by
multiple regulatory conlponents of the IGF systenl, including IGF-I and IGF-II, type I
and type II IGF receptors, at least six high-affinity IGF-binding proteins (IGFBP-l to -6),
and IGFBP proteases. The mature IGF-I peptide has four contiguous domains termed B,
C, A, and D, which are highly conserved among mammals. In vitro, IGFs increase AP
activity, a marker of differentiation (4). IGF-I stimulates collagen synthesis and decreases
collagen degradation, which is consistent with the inhibitory effect ofIGF-I on interstitial
C'ASE expression in rat osteoblast cultures (5). IGF-I also inhibits osteoblast apoptosis
(6) (7).
In vivo, IGF-I was originally proposed to act in an endocrine manner to mediate
the actions of growth hormone (GH), which was coined the "somatomedin hypothesis"
(8). This hypothesis states that somatic growth is regulated by GH, which primarily acts
on liver to stimulate IGF-I production. IGF-I then enters the circulation, reaches its target
tissues and regulates cell function. The critical role of the IGF system has been
5established in mice by genetic ablation of genes for IGF-I and IGF-II and their receptors.
Igfl-/- mice are 40% smaller than wild type littermates and have a higl1 perinatal lethality
rate. Igfl-/- mice that survive the prenatal period have severe growth retardation and are
infertile. These data suggest that IGF-I plays a role in both prenatal and postnatal growth
and development (9,10). Knockout of the igf2 gene in mice results in severe fetal growth
retardation; the animals are smaller at birth (60% of normal size) than igfl-/- mice (9)
(10). Ablation of the igflr gene results in more profound prenatal growth retardatiol1 than
disruption of either igfl or igf2 alone because both IGF-I and IGF-II signal through igflr
(11). Using ere/lox technology, liver specific igfl knockout mice were developed (11).
These mice have a 75% reduction in serum IGF-I levels with little impairment of growth,
indicating that local production ofIGF-I regulates body growth.
Transgenic n1ice with generalized IGF-I overexpression have contributed to our
understanding of IGF action in development and growth (12). Tissue-specific
overexpression ofIGF-I in mice has been used to study the local actions ofIGFs. Zhao et
al generated transgenic mice with osteocalcin promoter driven IGF-I to examine the
effects of locally produced IGF-I in bone (13). These mice sl10w increased matrix
apposition rate at 3 weeks of age and greater bone volume and density at 6 weeks of age,
at which tin1e peak bone mass is achieved in the mouse. There were no differences in
cortical bone width at 3- and 6-weeks of age and no differences in static or dynamic bone
histomorphon1etric paran1eters at 24 weeks; there were also no differences in calvarial
width and porosity. However, there was an increase in bone formation in the absence of
6increase in osteoblast number, suggesting that the primary effect of IGF-I is to increase
osteoblast function.
Jiang et al developed pOBCoI3.6-IGF transgenic mice expressing IGF- I in bone
driven by a 3.6 kb fragment of the type I collagen (Collal) promoter (14). This study
showed that calvariae from pOBCoI3.6-IGF mIce had increased rates of collagen
synthesis and cell replication in vitro, and increased calvarial width and
histomorphometric resorption parameters in vivo. The phenotype was dependent on
transgene dosage. They concluded that IGF-I can increase bone turnover. Osteoblast
cultures from pOBCoI3.6-IGF mice provide a unique model to examine the
autocrine/paracrine effects of IGF-I on proliferation and differentiation
GENERAL OBJECTIVE
To examIne the autocrine/paracrine effects of IGF-I on the proliferation and
differentiation of cells of the osteoblast lineage using primary calvarial cells from
pOBCoI3.6-IGF-I transgenic mice.
• Hypothesis: Transgenic overexpression ofIGF-I in osteoblasts stimulates
proliferation and osteogenic differentiation
SPECIFIC OBJECTIVES
1. To examine primary osteoblast cultures established from pOBCoI3.6-IGF-I mice
for cell growth by measuring cell number over time.
2. To examIne prImary calvarial osteoblast cultures established from transgenic
pOBCoI3.6-IGF mice for the expression of differentiation markers by Northern
blot analysis and reverse transcriptase-polymerase chain reaction (RT-PCR),
including OC, BSP, Collal, AP and the formation of mineralized nodules.
3. To examine prImary osteoblast cultures established from pOBCoI3.6-IGF-
I/CoI2.3-IGF mice for CoI2.3-GFP expression, a late marker of osteoblast
differentiation. GFP fluorescence will be analyzed by fluorimaging whole
cultures.
7
MATERIALS AND METHODS
Transgenic mice
Mice carrying the pOBCoI3.6-IGF transgene were previously generated by
embryo microinjection in the Transgenic Animal Facility (now called the Gene Targeting
and Transgenic Facility) at the University of Connecticut Health Center. The transgene
contains 3.6 kb of the rat Collal promoter, a sn1all segment of the rat Collal first intron,
most of the rat Collal first exon, the murine IGF-I cDNA and the bovine growth
hormone polyadenylation site (14). A FLAG epitope was placed between the signal
peptide and the coding region of IGF-I (Figure lA). Transgenic (TG) lines were
established by breeding the founder lines with CD-l mice. TG line 99-324-7 was used
for these experiments. Hemizygous TG male mice were breed with wild type (WT)
female CD-l n1ice. Roughly half of the resulting progeny were hemizygous TG, the
other half WT. Genotypes of the offspring were determined by PCR of tail DNA. All
animal work was performed in compliance with the guiding principles in the "Care and
Use of Animals" in the American Journal of Physiology, using protocols approved by the
Animal Care and Use Con1mittees of the University of Connecticut Health Center,
Farmington, CT (protocol number 2004-18). For most experiments, hemizygous
pOBCoI3.6-IGF mice were crossed with homozygous CoI2.3-GFP mice to generate
pOBCoI3.6-IGF (TG) and wild type (WT) progeny in a hemizygous CoI2.3-GFP
background. There was usually an equal representation of each genotype in the litters.
8
9Genotyping by peR
Mouse tail genonlic DNA was extracted using the Wizard genomic DNA
extraction kit (Promega, madison, WI, USA). PCR genotyping was carried out using
primers corresponding to first intron of rat Collalgene
(5'ACCCTCCTCCATTTTAGCC-3') and the FLAG sequence
(5'CATCGTCGTCCTTGTAGTC-3'), which generates a unique 700 bp transgene
product. DNA from WT mice does not give a product (Figure IB). PCR cycles were
94°C, 30 sec; 65°C, 30 sec; 72°C, 2 min. The cycle number was 32. PCR products were
fractionated by electrophoresis on a 1% agarose gel in IX TBE buffer and visualized by
ethidium bromide staining.
All the experiments were done in primary cell cultures. For each individual
experiment independent cell digestions were perfornled. For cell growth experiments four
wells per group were analysed. For AP staining, AP activity and von Kossa staining
experiments, three wells per group were analysed. For Northern blot analysis and GFP
expression studies, one sample per group was analysed. All experiments were repeated at
least 011ce and in most cases twice.
Primary osteoblast cultures
Calvarial osteoblasts were obtained from 6- to 8-day-old neonatal calvariae from
WT and TG mice. During this time, the presence of the pOBCoI3.6-IGF tral1sgene in
offspring was determined by PCR of tail DNA. After genotyping results were obtained,
hemicalvariae of the same genotype were grouped and subjected to four sequential 15-
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min digestions at 37°C on a rocking platform with an enzyme mixture consisting of 1.5
U/ml collagenase P in PBS and 0.05% trypsin/1mM EDTA. The first digest was
discarded. The second to fourth digests were pooled. The cell pellet was collected after
centrifugation at 2000 rpm for 10 nlin. Cells were resuspended in DMEM and passed
through a 40 J.lnl cell strail1er. Cell numbers were counted using Coulter Counter
(ColLlter Corporation, Miami, USA). Cells were plated at an initial density of 15000
cells/cm2 per well in 6-well culture dishes (Costar, Coming, NY) in DMEM containing
10% FBS and PIS. Medium was changed after 24 h and again on day 4. Osteogenic
differentiation agents, 50 J.lg/ml ascorbic acid and 4 mM B-glycerophosphate, were added
to the medium. Cultures were fed with medium containing fresh differentiating
supplements every other day for the duration of the experiment.
RNA extraction and Northern blot analysis
RNA was extracted from primary calvarial osteoblast culture on days 7, 14, and
21 using the TRIzOL method. A 0.8 ml aliquot of TRIzOL Reagent (Life Technologies,
Grand Island, NY, USA) was added to each culture well. Cells were transferred to 15 ml
polypropylene tubes (Falcon, Becton Dickinson, Franklin Lakes, NJ) and immediately
homogenized with a Polytron (PowerGen 700, Fisher Scientific) for 30 sec. Chloroform
was added to tubes to give a final concentration of 1:5 (vol/vol). Tubes were mixed on a
Vortex for 15 sec, and phases were allowed to separate for 5 sec. After centrifugation at
9,000 rpm for 20 min at 4°C, the upper phase was transferred to a fresh polypropylene
tube. After isopropanol precipitation, the pellet was re-dissolved in 300 J.lI of GTC buffer
(4.5 M guanidinium isothiocyanate, 10 mM B-mercaptoetllanol, 15 mM sodium N-Iauryl
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sarcosine and 10 mM sodium citrate, pH 7.0) followed by precipitation with 300 J.lI
isopropanol. The precipitate was washed once with 80% ethanol, drained and re-
dissolved in 50 J.lI of diethylpyrocarbonate (DEPC) treated water.
For Northern blot analysis, 12-20 J.lg of RNA from each group was denatured,
loaded onto a 1% agarose gel with 6% formaldehyde and size fractionated by
electrophoresis in MOPS buffer. RNA was transferred onto a Gene-Screen plus
Hybridization Transfer nlembrane (PerkinElnler Life Sciences, Inc. Boston, MA) by
capillary pressure. RNA was cross-linked to each membrane by UV irradiation.
Prehybridization of eacll membrane was performed in IX Pre-Hyb solution (Molecular
Research Center, Cincinnati, OH) at 42°C for at least 3 h, followed by hybridization
overnight with 32P-Iabeled cDNA probes in a high efficiency hybridization system
(Molecular Research Center, Cincinnati, OH) at 42°C with 5-6 million cpm/ml for each
probe. The following cDNA probes were used: rat Col1al, mouse BSP, mouse OC and
chick B-actin. Probes were labeled using the random primer method using [32p]dGTP
(3000 Ci/nlmol, New England Nuclear, Boston, MA). Membranes were washed and
exposed to a phosphoimager. The intensity of the radioactive signal was quantified using
ImageQuant. Kodak BioMax MR- photographic film (Sigma Chemical Co., St. Louis,
MO) was placed over the membrane with an enhancing screen for exposure at -80°C, and
developed using a Kodak developer. The signal obtained with each cDNA was
normalized to the signal obtained by hybridization with a radiolabeled B-actin probe.
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RT-peR for transgene expression
RNA (3 JJ-g) was reversed transcripted into cDNA in the presence of oligo (dT)
primers, RNase inhibitor and M-MLV reverse transcriptase at 42°C. After heating at
80°C for 10 min, PCR was performed using the RT product and transgene specific
prinlers corresponding to the Col1a1 first exon (5'-AGCAGACGGGAGTTTCACCTC-
3') and the FLAG epitope (5'-CATCGTCGTCC TTGTAGTC, which produce a 400 bp
band. PCR was carried out with a Perkin Elmer GeneAmp system at 94°C for 30 sec,
65°C for 30osec, and 72°C for 2 min for 25 cycles. Amplified products were fractionated
by electrophoresis on a 5% polyacrylamide gel and visualized by ethidium bromide
staining. The transgene band was normalized with murine glyceraldehyde 3-phosphate-
dehydrogenase (G3PDH), which was assessed using the RT product and a primer pair
that amplifies a 983 bp band.
AP staining and activity
AP expression in cell cultures was detemlined by histochemical staining and a
quantitative activity assay. For AP staining, cells were rinsed twice with phosphate-
buffered saline (PBS) and fixed with 2% paraformaldehyde. An AP substrate mixture
(AP staining kit, Sigma Diagnostic, Inc., St. Louis, MO) was added and the plates were
incubated at room temperature, while protected from light, for 15 min for color
developmel1t.
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For AP activity assays, cell layers were removed from the culture plates in
scrapping buffer (0.04M Tris, 1 mM EDTA, 0.15 M NaCI); cell pellets were collected
after a brief centrifugation. Cells were lysed in Tris buffer (10 mM Tris, 0.15% Triton x
-100) and subjected to 3 free-thaw cycles. After centrifuge at 14,000 rpm for 5 min,
supernatant was collected. A 20J.lI aliquot of supernatant from each sample was added to
each well in duplicates in a 96-well plate (Costar, Coming, NY), and incubated with an
assay mixture of p-nitrophenyl phosphate. Plates were scanned for spectrophotometric
analysis using a plate reader (J.lQuant plate reader, Bio-Tek, Winooski, VT). Absorbance
is measured at 410 nm every 5 minutes for 30 min. Activity was calculated using KC
junior software (Bio-Tek, Winooski, VT). AP activity was expressed as nmol/min/n1g.
Von Kossa staining
Mineralization of the cells was assessed by the von Kossa method. Cells were
fixed for 10 min in 2% paraformaldehyde in 0.1 M cacodylic buffer. The plates were
incubated with 5% silver nitrate solution for 30 min under a bright light, washed with
water, treated with a 5% sodium thiosulfate solution for 2-3 min, followed by washing
with water and air drying. The von Kossa positive area of each well was quantitated by
threshold segmentation using Metamorph image processing software (Center for
Biomedical Imaging Technology, UCHC).
Fluorescence microscopy
GFP fluorescence in cell culture was visualized using an Olympus IX50 inverted
microscope equipped with an IX-FLA inverted reflected light fluorescence (Olympus
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America, Inc, Melville, NY). A specific excitation wavelength was obtained using filters
for GFPtpz (exciter: D500/20; dichroic: 525DCLP; emitter: D550/40) and recorded with
a SPOT-camera (Diagnostic Instruments, Inc., Sterling Heights, MI). Fluorescent images
were taken with equal exposure times for all groups. Phase contrast bright-field images
were converted to grayscale. Magnifications of 4X, 10X and 20X were used. Bright-
field/fluorescent composite images are generated using Adobe Photoshop software. The
distribution and quantification of GFP fluorescence in cell culture was performed with
FluorImager SI (Molecular Dynamics, Sunnyvale, CA, USA) using a 515-run emission
spectrum at PMT settings of 800. Images were processed with Image QuaNT software
(Molecular Dynamics) and quantified by threshold segmentation using Metamorph image
processing software (Center for Biomedical Imaging Technology, UCHC).
Statistics
The comparison of means between WT and TG groups was determined with the
unpaired t-test. A value of p<0.05 was considered to be a significant difference between
groups.
RESULTS
pOBCoI3.6-IGF transgenic mIce were generated by Jiang et al as described
previously (14). Transgenic mice were identified by genotyping DNA from tail biopsies
and performing PCR using transgene specific primers. Hemicalvaria from 6-8 day old
neonatal mice were extracted and pooled based on genotyping results. Primary cells were
prepared by serial enzymatic digestion and cell proliferation and differentiation was
assessed by various n1ethods.
Cell proliferation in WT and TG primary osteoblast cultures
Primary osteoblasts were obtained by sequential enzymatic digestion of calvariae
from 6-8 day- TG and WT mice. Cells were plated at an initial del1sity of 40,000
cells/cm2 (day 0) in 12-well culture plates and cell number per well was determined daily
on days 1-7. A total of five experiments were done. Based on the cell number of cells
plated on day 0, cell number was reduced by 20 percent in WT and by 40 percent in TG
cultures on day 1 of culture. This indicated that the actual number of cells plating down
was 60-80%. Cell growth in both groups slowed between days 3 and 4 (Figure 2A). At
each day, there was only a small difference in cell number between WT and TG groups.
However, the daily percentage increase in cell number was greater in TG cultures at days
4 and 5 (Figure 2B).
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Osteoblast differentiation in WT and TG primary osteoblast cultures
Osteoblast differentiation was determined by measuring AP activity, von Kossa staining,
GFP expression and osteoblast mRNA markers by Northern blot analysis.
AP activity
At days 14 and 21, AP staining was performed on three wells per group and AP
activity was measured in three wells per group in a total of three experiments (Figure
3A). There was no noticeable differel1ce between AP staining of WT and TG cultures. AP
activity was measured as an early differentiation marker on days 14 and 21. No
significant difference was seen in AP activity between TG and WT cultures at day 14. A
50% decrease in AP activity was seen in TG cultures at day 21 (Figure 3B).
Von Kossa staining
Mineralization was assessed by von Kossa staining at day 21. Von Kossa staining
was assessed as a late differentiation marker in the same wells as AP staining in two
experiments (Figure 4A). The von Kossa positive area of each well was quantitated by
image analysis. There was no difference in von Kossa staining between WT and TG
cultures (Figure 4B).
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GFP expression
pOBCoI2.3-GFP expression was used as a visual marker for late stage
differentiation. GFP fluorescence was observed using fluorescent microscopy (Figure5A)
and quantified by Fluorimaging using Image QuaNT software, followed by threshold
segmentation using Metamorph image processing software (Figure 5B). Expression was
seen on day 14 in both groups. GFP was strongly expressed in bone nodules within the
cultures. Similar patterns and intensities of GFP were seen in WT and TG cultures. When
the data from three experiments were pooled, there was no difference in pOBCoI2.3-GFP
expression in WT and TG cultures (Figure 5C).
mRNA markers
The expression of osteoblast differentiation markers including Collal, BSP, and
OC was determined by Northern blot analysis in three experiments (Figure 6A). All
hybridization signals were normalized to actin. On day 7, OC and BSP mRNAs were not
expressed in either WT or TG cultures. On day 7, Collal was expressed in both WT and
TG cultures. There was a trend (O.5<p<O.1) towards lower Collal expression in TG
cultures. On days 14 and 21, Collal, BSP, and OC were expressed in both WT and TG
cultures (Figures 6B and C). The relative expression of Collal in TG cultures increased
between days 7 and 14 (Figure 6D). There was no difference in expression of these
markers between WT and TG cultures.
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Transgene expression
To measure transgene expression through out tIle culture period, transgene specific
primers were used for RT-PCR analysis. The primers, corresponding to the Collal exon
and FLAG epitope (Figure 7A), generated a unique ,,-,400 bp product with TO RNA. Cells
from WT mice did not express the transgene (Figure 7B). In cells from TO mice,
transgene mRNA was detected as early as day 7 and appeared to increase through out the
culture period. The transgene band was normalized with murine glyceraldehyde 3-
phosphate-dehydrogenase (03PDH), which was assessed using the RT product and a
prinler pair that amplifies a 983 bp band
DISCUSSION
Bone remodeling is regulated by many horn10nes and growth factors including
IGF-I. Understanding the cellular and molecular mechanisms and action of these factors
will provide a better understanding of their role in normal and pathological bone
remodeling. It is well known that IGF-I plays an essential role in normal growth and
development. IGF-I exerts an anabolic action on protein and carbohydrate metabolism
and regulates cellular activities involving cell proliferation, differentiation, and apoptosis
(15).
To gaIn insight into the role of locally-produced IGF-I in bone, Jiang et al
developed a transgenic mouse model with osteoblast-directed overexpression of IGF-I
(pOBCoI3.6-IGF). This model showed evidence of increased bone turnover (14).
Calvariae were wider and increased porosity. Calvarial organ cultures from TG mice
showed increased rates of collagen synthesis and thymidine incorporation, a measure of
cell replication.
To understand the cellular and molecular mechanisms underlying the bone
phenotype ofpOBCoI3.6-IGF mice, we examined osteoblast differentiation and bone cell
proliferation in ex vivo cultures of primary osteoblasts established from TG and WT
calvariae. We reasoned that the IGF-I transgene would become activated during the
primary culture and have an affect on proliferation and/or osteoblast differentiation.
19
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Primary calvarial cell cultures contain precursor cells for osteoblasts. They can be
induced to undergo osteogenic differentiation and express osteoblastic markers in vitro in
the presence of serum, ascorbic acid and B-glycerophosphate. These cells express
multiple growth factors and their receptors including IGF-IR. The phenotype of primary
calvarial osteoblasts may reflect their behavior in vivo. Therefore, studying the
proliferation and differentiation in wild type and pOBCoI3.6-IGF primary calvarial
osteoblasts may provide insight into the mechanisms by which IGF-I regulates bone
turnover in vivo.
We found that cell growth was higher in TG cultures compared to WT cultures.
This finding was consistent with the finding in previous studies showing that IGF-I
increase cell growth and proliferation (15). The reduced cell number one day after plating
probably indicated that all of the plated cells did not adhere to the dishes. By day 5 and 6,
cells reached confluence. The increase in cell growth could be attributed to either an
increase in cell proliferation or a decrease in apoptosis. These were not measured in the
present study.
AP was used as an early marker of osteoblast differentiation. Other early markers
are Colla1 and activated leucocyte cell adhesion molecule (ALCAM). Compared to WT
cells, there was a significant decrease in AP activity in TG cells on day 21 but not at day
14, indicating that late osteoblast differentiation was affected. However, the expression of
other osteoblast markers including Col1a1, BSP and OC, von Kossa staining and GFP
expression were not altered in TG cultures. Thus, the inhibitory effect on osteoblast
21
differentiation was relatively nl0dest and limited to a decrease in AP expreSSIon.
However, in addition to IGF-I, neonatal mouse calvarial cells also produce other growth
factors such as IGF-II, TGF~, and PDGF (16). Therefore, the interplay of multiple
growth factor pathways is probably required for osteoblast proliferation and
differentiation. It remains to be determined whether the lack of effect of the IGF-I
transgene on osteoblast differentiation was the result of an increase in cell growth or the
in vitro environment.
The increased expreSSIon of IGF-I in transgene bone could have produced
compensatory changes in other components of the IGF-I pathway including expression of
IGFBPs and IGF receptors (17, 18). For example, if the transgene led to an increase in
IGFBP expression, this could mitigate the effect of transgenic IGF-I.
It has been demonstrated that IGF-I stimulates the proliferation of pre-osteoblasts
to increase the pool of osteogenic progenitors, and promotes the progression of pre-
osteoblasts to full osteoblast differentiation (19). However, the exact mechanisms through
which IGF-I regulates osteoblast lineage progression remain unclear. Some investigators
proposed that the effects of IGF-I are not nlediated via targeting osteoprogenitors, but are
largely restricted to more mature osteoblasts to maintain their differentiation (20-22).
Results from our study demonstrate that IGF-I may affect proliferation rather than
differentiation of primary calvarial osteoblasts because more prominent effects were
observed on cell growth.
Based on this data, we conclude that IGF-I overexpression driven by the 3.6-kb Colla!
promoter fragment in primary calvarial osteoblasts from transgenic mice showed an
increase in osteoblast proliferation but had no significant effect on differentiation.
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SUMMARY AND CONCLUSIONS
The acquisition and maintenance of bone mass are complex processes regulated
by systemic hormones and local growth factors. IGF-I plays an essential role growth,
skeletal developmel1t and bone nlass acquisition. IGF-I acts in both an endocrine
manner, as it is produced and secreted by liver, and in a paracrine/autocrine manner, as it
is produced by osteoblasts, to exert growth hormone-dependent and growth hormone-
independent effects on bone.
A tremendous amount of knowledge has been gained regarding the in vivo actions
of IGF-I with the development of transgenic and mutant animal models. To understand
the cellular and molecular mechanisms underlying the bone phenotype of pOBCoI3.6-
IGF mice, we examined osteoblast differentiation and bone cell proliferation in ex vivo
cultures of primary calvarial osteoblasts established from TG and WT calvariae. We
found that cell growth was higher in TG cultures compared to WT cultures. A significant
decrease in AP activity in TG cells was noted on day 21 il1dicating that late osteoblast
differentiation was affected. Expression of other osteoblast markers including Collal,
BSP and OC, von Kossa staining and GFP expression were not altered in TO cultures.
The irlhibitory effect on osteoblast differentiation was relatively modest and limited to the
decrease in AP expression. Thus, results from our study demonstrate that IGF-I may
affect proliferation rather than differentiation of primary calvarial osteoblasts.
The increase in cell growth could have been due to increased cell proliferation or
decreased apoptosis. A further study measuring cell proliferation (thymidine and Brdu
23
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incorporation) and apoptosis (TUNEL assay and caspase activity) would give clear
insight into the mechanism for increased cell growth in TG cultures.
Another possibility in the pOBCoI3.6-IGF model could have been compensatory
cilallges in other components of the IGF-I pathway including expression of IGFBPs and
IGF receptors. A logical extension of our work would be to examine the expression of
IGFBPs In cultured osteoblasts including IGFBPs 2 and 4.
Figure 1. Schematic diagram of the pOBCoI3.6-IGF transgene and PCR
genotyping of mice
A) The pOBCoI3.6-IGF transgene contains a rat Collal gene fragment from -3518 to
+1594 bp, including 3.6 kb of Collal promoter sequence and part of the Collal first
exon (CoI3.6) and most of the Collal first intron, murine IGF-I cDNA (IGF-I) in which
the FLAG (FL) epitope was inserted between the signal peptide (SP) and the mature
coding region of IGF-I and the bovine growth hormone polyadenylation sequence (pA).
PCR genotyping was carried out using primers corresponding to regions of the Collal
first intron and the FLAG epitope as shown by the arrows.
B) A typical PCR genotyping analysis of progeny generated by breeding a hemizygous
pOBCoI3.6-IGF transgel1ic (Tg) mouse with a wild-type (Wt) mouse. DNA was extracted
from tail biopsies and amplified by PCR using the as described in the Methods and
Materials. DNA fronl Tg animals gives a unique 700 bp transgene product. M, 0X
molecular weight size markers. Lanes labeled P and B indicate a positive control and a
water blank, respectively. The remaining lanes indicate the genotyping results for
individual progeny, which were found to be Tg or Wt.
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Figure 2. Cell growth in primary calvarial osteoblast cultures.
A) Cell growth in wild type (Wt) and transgenic (Tg) cultures from day 1 to day 6. The
graph is representative of five independent experiments.
B) Percent cell growth during defined intervals in Wt and Tg cultures from day 1 to day
6. At each day, cell nunlber in Wt cultures was set to 1.0 and the ratio of cell number in
Tg compared to Wt cultures was calculated. Each value is the mean ± SEM of five
experiments. The graph shows results pooled from five independent experiments.
*Different from Wt, p<O.05.
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Figure 3. Alkaline phosphatase staining in primary osteoblast cultures.
A) Alkaline phosphatase (AP) staining of wild type (Wt) and transgenic (Tg) cultures on
day 21. The white areas in the cultures represent mineralization.
B) AP activity in Wt and Tg cultures on days 14 and 21. Each value is the mean ± SEM
of three experiments. For each experiment AP activity in Wt cultures was set to 1.0 and
the ratio of AP staining in Tg compared to Wt cultures was calculated. Data shown were
pooled from three independent experiments. *Different from Wt, p<0.05.
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Figure 4. Mineralization in primary calvarial osteoblast cultures.
A) Following alkaline phosphatase (AP) staining, day 21 wild type (Wt) and transgenic
(Tg) cultures were stained with Von Kossa to assess mineralization. The black color
represents mineralization.
B) Image analysis to quanitate mineralization. The von Kossa stained areas on day 21 Wt
and Tg cultures were imaged as described in Materials and Methods. Von Kossa stained
area in Wt cultures was set to 1.0 and the ratio of von Kossa staining in Tg compared to
Wt cultures was calculated. Each value is the mean ± SEM of four cultures. Data shown
were pooled fronl three independent experiments.
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Figure 5. GFP expression in primary calvarial osteoblast cultures.
A) Hemizygous pOBCoI3.6-IGF mice were breed with homozygous pOBCoI2.3-GFP
mice to generate progeny that were transgenic (Tg) or wild type (Wt) with respect to the
pOBCoI3.6-IGF transgene in a hemizgyous pOBCoI2.3-GFP background. GFP
fluorescence in Wt and Tg cultures is shown at two magnifications (4x and lOx).
B) Fluorimager images ofGFP expression in day 14 and 21 Wt and Tg cultures.
C) Quantification of GFP fluorescence by fluorimaging on day 21 Wt and Tg cultures.
GFP fluorescence in Wt cultures was set to 1.0 and the ratio of GFP fluorescence in Tg
compared to Wt cultures was calculated. Each value is the mean ± SEM of six cultures.
Data shown were pooled from three independent experiments.
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Figure 6. Expression of mRNA markers in primary osteoblast cultures.
on days 7, 14, and 21 as assessed by Northern blot analysis. Data shown are
representative of three independent experiments.
A) Northern blot gel. RNA was extracted from wild type (Wt) and transgenic (Tg)
cultures and subjected to Northern blot analysis as described in Material and Methods.
The gel was probed with Collal, BSP, OC and actin cDNAs (top). Ethidium bromide
staining of 28S and l8S ribosomal RNA is shown (bottom). For each Northern blot
experiment, the intensity of the bands were quantitated using a phosphorimager and the
ratio ofmRNA expression to actin was indicated. This value in Wt cultures was set to 1.0
and the ratio of gene expression in Tg compared to Wt cultures was calculated. Each
value is the mean ± SEM. Data shown were pooled from three independent experiments.
B) Quanititaion ofOC mRNA expression. C) Quantitation ofBSP mRNA. D)
Quantitation of ColI al mRNA expression.
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Figure 7. Expression ofpOBCoI3.6-IGF transgene mRNA expression by RT-PCR
analysis.
RNA (3 J.lg) from day 7, 14 and 21 wild type (Wt) and transgenic (Tg) cultures was used
in a RT-PCR analysis with primers corresponding to the rat Colla1 first exon and the
FLAG epitope. In Tg cultures, this analysis produced a 400 bp product. P, positive
control; B, water blank; ~X, molecular weight markers. RNA integrity was verified by
amplification with G3PDH primers.
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